Skip to content

Clinical trials

Lung Diseases, Interstitial trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases, Interstitial Country / region: Brazil Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20173
20191
20204
20212
20224
20232
20244
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting5
Terminated4
Active, not recruiting3
Unknown status3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim5
GlaxoSmithKline3
Bristol-Myers Squibb2
Hospital do Coracao2
Celgene1
Federal University of Minas Gerais1
Gilead Sciences1
Insmed Incorporated1
Kyntra Bio1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases, Interstitial24
Pulmonary Fibrosis8
Idiopathic Pulmonary Fibrosis5
Fibrosis4
Lung Diseases4
Connective Tissue Diseases3
Idiopathic Interstitial Pneumonias3
Sarcoidosis3
Arthritis, Rheumatoid2
Hypertension, Pulmonary2

Trials

Showing 51 to 24 of 24. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.